Ketamine-midazolam
DrugKetamine 300-500mcg/kg plus midazolam 0.03 mg/kg once.
Other names: Ketaral
NCT Number: NCT01807429
the investigators assessed the effects of low-dose IV ketamine-midazolam versus morphine on pain control in trauma patients with closed limb fracture(s); and also compared the incidence of adverse events (mainly cardio pulmonary ) between two groups.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Phase 2 / Phase 3
this prospective, single blind, noninferiority trial randomized consecutive ED patients aged 18 to 60 years to two groups: receiving either 300-500 mcg ketamine plus 0.03 mg midazolam, or 0.05 to 0.1 mg morphine. Visual analogue score and adverse events were carefully verified during an interval of 30 minutes.
Two hundreds, thirty six patients were selected, among whom were 207 males (87.3%), and 29 females (12.2%). The average age was 29±2, with extremes of 60 years and 18 years.the patients were divided into two groups: G1: 116 patients receiving ketamine-midazolam and G2: 120 patients receiving morphine alone.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ketamine 300-500mcg/kg plus midazolam 0.03 mg/kg once.
Other names: Ketaral
morphine 0.05 mg/kg
Other names: Avinza
Time frame: 30 minutes
the pain score was verified at the outset and every 10 minutes after administration of analgesics.
Time frame: 30 minutes
the variables were assessed for an interval of 30 minutes.
Time frame: 30 minutes
the patients were closely observed for any drug induced adverse events.
Isfahan University of Medical Sciences
Other
Comparing Low Dose IV Ketamine-midazolam Versus IV Morphine Regarding ED Pain Control in Patients Sustaining Closed Limb Fracture(s)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.